Clinic
South Texas Family Planning & Health Corporation
South Texas Family Planning & Health Corporation was paid $745K by Medicaid between Jan 2018 and Nov 2024, across 29 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 21% of everything it billed.
33Billing provider infoSOUTH TEXAS FAMILY PLANNING & HEALTH CORPORATION
BEEVILLE, TX 78102
BEEVILLE, TX 78102
33aNPI1922151828assigned 01/22/2007
33bProvider typeAmbulatory Family Planning Facility
28Total paid$745K
24GClaims35,185
24DCodes billed29
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ambulatory Family Planning Facility providers in Texas
Rank by total paid#9 of 73
Median peer was paid$144K
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 270 | $3K | |
| 2019 | 214 | $2K | |
| 2020 | 6,185 | $134K | |
| 2021 | 8,815 | $200K | |
| 2022 | 10,493 | $223K | |
| 2023 | 8,131 | $168K | |
| 2024incomplete | 1,077 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S4993 | Contraceptive pills for birth control | 21% | 1,466 | 1,438 | $157K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 15% | 1,672 | 1,655 | $115K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 4,286 | 4,032 | $114K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 12% | 1,486 | 1,478 | $92K |
| A4267 | Contraceptive supply, condom, male, each | 8.2% | 8,997 | 8,323 | $61K |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | 7.9% | 85 | 79 | $59K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 1,731 | 1,682 | $19K |
| 80061 | Lipid panel | 2.4% | 2,430 | 2,394 | $18K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 2.3% | 24 | 24 | $17K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 952 | 937 | $17K |
| 81025 | 2.0% | 2,220 | 2,165 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 2,077 | 2,047 | $12K |
17 more codes
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | 1.2% | 609 | $9K |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 318 | $7K |
| A9150 | Non-prescription drugs | <1% | 449 | $6K |
| 82947 | <1% | 2,372 | $5K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 12 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 112 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 112 | $3K |
| 81003 | <1% | 1,221 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 60 | $2K |
| 85018 | <1% | 1,061 | $2K | |
| 85014 | <1% | 871 | $2K | |
| 99385 | <1% | 26 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 29 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 186 | $1K |
| 90688 | <1% | 50 | $738.38 | |
| 99000 | <1% | 17 | $181.44 | |
| J3490 | Unclassified drugs | 0% | 254 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZUNIGA, MARTHA (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| South Texas Family Planning & Health Corporation | Corpus Christi, TX | $1.32M |
| South Texas Family Planning & Health Corporation | Kingsville, TX | $593K |
| South Texas Family Planning & Health Corporation | Sinton, TX | $379K |
| South Texas Family Planning & Health Corporation | Rockport, TX | $307K |
| South Texas Family Planning & Health Corporation | Robstown, TX | $137K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.